Thursday, 22 Jun 2017

You are here

EULAR 2017 – Day 1 Highlights

The Annual EULAR Congress kicked off this afternoon in Madrid with a number of new sessions devoted to:

  • Criteria revision in lupus, Sjogren's syndrome and the antiphospholipid syndrome
  • The cancer – autoimmunity balance and the lessons learned from checkpoint inhibitors and the development of Immune Related Adverse Events (IRAEs)
  • Wearable technologies
  • New EULAR campaign “Don’t Delay, Connect Today”.  (Promoting early diagnosis and the role of early interventions (including drug and lifestyle interventions)
  • Progress in Spondyloarthritis Management
  • Comorbidities and Rheumatic disease

Posters start tomorrow.

For many it was a day of meeting up with international colleagues and avoiding the 100 degree heat. (Burger King's air conditioning seems to be very appealing)

 

Disclosures: 
The author has no conflicts of interest to disclose related to this subject

Add new comment

More Like This

EULAR 2017 – Day 4 Highlights

Saturday was a day of big posters and special seminars at EULAR in Madrid.  In the morning, I passed on an interesting session on nailfold capillaroscopy led by Dr. M Cutolo and went to a JIA outcomes session. I reported on this in a video from day 4 (Saturday) called “Long-Term Comorbidities in JIA” – you can find it here.

Responder Criteria for Nonpharmalogical Treatment of Fibromyalgia.

Because of the subjective nature of fibromyalgia symptoms, tools for monitoring of disease activity and/or treatment assessment tools to evaluate effectiveness of nonpharmacological modalities are difficult to develop.

Concomitant Septic Arthritis and Crystalline Arthropathy

Researchers sought to describe the characteristics of patients with concurrent septic and crystal arthritis through a retrospective analysis of patients with the concomitant diagnoses between 1985-2015 at a university hospital in Spain.

EULAR 2017 – Day 3 Highlights

Friday was a mega-day in Madrid as this day all the late-breaking abstracts were presented, in addition to the bulk of high-impact podium presentations in several areas.

Here are the major presentations from several clinical areas.

Herpes Zoster

Today during the comorbidities in RA session, Dr. Leonard Calabrese spoke about herpes zoster (HZ). Given the frequency of HZ in immunocompetent persons and the fact that patients with IMIDs carry at least twice the risk of developing HZ, it is important for rheumatologists to be informed about diagnosis, treatment and most importantly prevention of HZ.